ReviewArchives of microbiology2023
Green synthesis of nanoparticles using botanicals and their application in management of fungal phytopathogens: a review.
Review in Archives of microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Biocatalytic and biogenic pathways for sustainable nanoparticle synthesis: mechanisms, monitoring, and circular bioeconomy integration.Bioprocess and biosystems engineering · 2026Review
- Antifungal and Anti-Oomycete Potential of AgInternational journal of molecular sciences · 2026Article
- Endophytic nanotechnology as a dual-action approach against agricultural and clinical fungal pathogens.Archives of microbiology · 2026Review
- Antifungal activities of Morinda lucida root extracts against Lasiodiplodia theobromae for post harvest disease management.Scientific reports · 2025Article
- Hierarchical plant extracts in silver nanoparticles preparation: Minuscular survey to achieve enhanced bioactivities.Heliyon · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green synthesis of nanoparticles is an emerging aspect in plant disease management that blends nanotechnology and plant-derived ingredients to produce a biocontrol formulation. Different physical and chemical processes employed in the synthesis of nanoparticles are polluting, expensive, and also release hazardous by- products. The range of secondary metabolites present in plants makes them efficient reducing and stabilizing agent during the synthesis process. These metabolites serve a vital role in plant defense against the invasion of phytopathogens including fungi, bacteria, viruses, insect pests, etc. The plant metabolites, such as sugars, terpenoids, polyphenols, alkaloids, phenolic acids, and proteins, have been shown to be crucial in the reduction of metal ions into nanoparticles. In green synthesis of nanoparticles, the plant extracts are used as potential reducing and capping. This also restricts the formation of clusters or aggregates and improves the colloidal stability. The nanoparticles exhibit excellent antimycotic against a variety of phytopathogens and are very efficient in managing plant diseases. The aim of this review is to highlight plants, phytochemicals exhibiting antifungal properties, green synthesis of nanoparticles using plant material and their antimycotic activity.
Indexed as
Identifiers
36800046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.